Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Xiaonian Tu"'
Autor:
Ligang Xia, Zhoufang Li, Bo Zhou, Geng Tian, Lidong Zeng, Hongyu Dai, Xiaohua Li, Chaoyu Liu, Shixin Lu, Feiyue Xu, Xiaonian Tu, Fang Deng, Yuancai Xie, Weiren Huang, Jiankui He
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-7 (2017)
Abstract Cell-free DNA (cfDNA) in plasma has emerged as a potential important biomarker in clinical diagnostics, particularly in cancer. However, somatic mutations are also commonly found in healthy individuals, which interfere with the effectiveness
Externí odkaz:
https://doaj.org/article/72223ec9b9014ea794371c47787bfe64
Autor:
Hsiao-Ching Yang, Chao Xu, Xifei Li, Xumei Yao, Fengjun Cao, Qian Y, Cheng F, Feiyue Xu, Jiankui He, Muyun Peng, Geng Tian, Chaoyu Liu, Xie Yuanhong, Bing He, Kong D, Fenglei Yu, Xiaonian Tu
BACKGROUNDEarly detection of lung cancer to allow curative treatment remains challenging. Cell-free circulating tumor DNA (ctDNA) analysis may aid in malignancy assessment and early cancer diagnosis of lung nodules found in screening imagery.METHODST
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::261392e66310a9c9504d8e4898390262
https://doi.org/10.1101/453803
https://doi.org/10.1101/453803
Autor:
Fengjun Cao, Fenglei Yu, Chaoyu Liu, Feiyue Xu, Yuancai Xie, Chuanbo Xu, Haoxian Yang, Bing He, Fangsheng Cheng, Youhui Qian, Geng Tian, Xiaohua Li, Muyun Peng, Xumei Yao, Xiaonian Tu, Deju Kong
Publikováno v:
Journal of Medical Genetics
BackgroundEarly detection of lung cancer to allow curative treatment remains challenging. Cell-free circulating tumour (ct) DNA (ctDNA) analysis may aid in malignancy assessment and early cancer diagnosis of lung nodules found in screening imagery.Me
Autor:
Muyun Peng, Yuancai Xie, Xiaohua Li, Youhui Qian, Xiaonian Tu, Xumei Yao, Fangsheng Cheng, Feiyue Xu, Deju Kong, Bing He, Chaoyu Liu, Fengjun Cao, Haoxian Yang, Fenglei Yu, Chuanbo Xu, Geng Tian
Publikováno v:
Journal of Medical Genetics; Oct2019, Vol. 56 Issue 10, p647-653, 7p
Autor:
Geng Tian, Feiyue Xu, Xuanbin Wang, Dan Yu, Yuancai Xie, Jiankui He, Fengjun Cao, Chaoyu Liu, Fenglei Yu, Xiaohua Li, Xumei Yao, Xiaonian Tu, Lu Shixin, Weiquan Zhong
BackgroundRemarkable advances for clinical diagnosis and treatment in cancers including lung cancer involve cell-free circulating tumor DNA (ctDNA) detection through next generation sequencing. However, before the sensitivity and specificity of ctDNA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5960e05125cbb4853ac135de2a12d070
https://doi.org/10.1101/189340
https://doi.org/10.1101/189340
Autor:
Xiaonian Tu, Fang Deng, Feiyue Xu, Yuancai Xie, Lidong Zeng, Lu Shixin, Ligang Xia, Xiaohua Li, Bo Zhou, Geng Tian, Jiankui He, Hongyu Dai, Zhoufang Li, Weiren Huang, Chaoyu Liu
Publikováno v:
Scientific Reports
Scientific Reports, Vol 7, Iss 1, Pp 1-7 (2017)
Scientific Reports, Vol 7, Iss 1, Pp 1-7 (2017)
Cell-free DNA (cfDNA) in plasma has emerged as a potential important biomarker in clinical diagnostics, particularly in cancer. However, somatic mutations are also commonly found in healthy individuals, which interfere with the effectiveness for canc
Autor:
Fengjun Cao, Lu Shixin, Fenglei Yu, Youhui Qian, Geng Tian, Dan Yu, Feiyue Xu, Xiaohua Li, Xiaonian Tu, Fangsheng Cheng, Xumei Yao, Chaoyu Liu, Jiankui He, Chuanbo Xu, Wenling Xie, Muyun Peng, Yuancai Xie, Bing He, Xuanbin Wang
Publikováno v:
Journal of Clinical Oncology. 36:e24036-e24036
e24036Background: Cell-free circulating tumor DNA (ctDNA) for cancer detection drew significant clinical attention. Concordance of mutations in tumor tissue and ctDNA should be evaluated first. Met...